Rebalix
SPDR · sheet of 5 September 2026
SPDR · sheet of 5 September 2026ETF sheet · official issuer and register data
State Street® SPDR® FTSE Global Convertible Bond USD Hdg UCITS ETF (Dist)
SPF2 · IE00BDT6FR16 · USD · domicile Ireland
Bonds · Convertible USD · Broad (all maturities) · GlobalUSD-hedged share classSFDR art. 6 (inferred)
Index tracked: FTSE Qualified Global Convertible Monthly Hedged (USD) Index
- TER
- 0.55%+ trans. 0.10%
- Fund size
- 2.7 bn EUR
- Tracking difference
- −0.52%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (sampled)
- Income
- Distributingsemi-annual
Launch 30 Jan 2022 · costs from the KID as of 2 Sept 2026 · 359 securities held · 2 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
Investment objective The objective of the Fund is to track the performance of the global convertible bond market. The Fund seeks to track the performance of the FTSE Qualified Global Convertible Index (the "Index") as closely as possible. The Fund is an index tracking fund (also known as a passively managed fund). Investment policies The Fund invests primarily in securities included in the Index. These securities include the investable, global convertible bond market (including mandatory convertible bonds and perpetual convertible bonds). Qualifying…
Performance since series start (in euro) — base 100
31 Jan 2022 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +25.8% |
| 3 years | +51.1% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +49.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 10.91% | 7.91% | — |
| Max drawdown | −6.36% | −6.90% | — |
| Sharpe | 1.83 | 1.57 | — |
| Sortino | 2.80 | 2.34 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SPF2 · IE00BDT6FR161
RebalixSPF2 · IE00BDT6FR16 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +22.98% | +23.39% | −0.41% |
| 2024 | +10.08% | +10.72% | −0.64% |
| 2023 | +13.04% | +13.54% | −0.51% |
| 2022 | −12.00% | −11.66% | −0.35% |
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 69.3%
Rating breakdown (% of fund)
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 0.2413 USD (0.53% of NAV) · last ex-date 9 Jul 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2413 | — |
| 2025 | 2 | 0.2395 | +0.73% |
| 2024 | 1 | 0.0534 | +0.18% |
| 2023 | 2 | 0.075 | +0.28% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
SPF2 · Börse Hamburg, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BDT6FR16
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BDT6FR16
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · SPF2 · IE00BDT6FR162